Financhill
Back

Gitlab, Inc. Vs. Rhythm Pharmaceuticals, Inc. Industry Stock Comparison

Sell
30

GTLB
Gitlab, Inc.

Last Price:
$40.69
Seasonality Move:
-20.64%
Buy
61

RYTM
Rhythm Pharmaceuticals, Inc.

Last Price:
$117.57
Seasonality Move:
-9.01%
Sell
30
Gitlab, Inc. (GTLB) is a Sell

Is Gitlab, Inc. a Buy, Sell or Hold?

  • The current Gitlab, Inc. [GTLB] share price is $40.70. The Score for GTLB is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • GTLB is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
61
Rhythm Pharmaceuticals, Inc. (RYTM) is a Buy

Is Rhythm Pharmaceuticals, Inc. a Buy, Sell or Hold?

  • The current Rhythm Pharmaceuticals, Inc. [RYTM] share price is $104.77. The Score for RYTM is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
  • RYTM is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

GTLB Stock Price Chart

What is Gitlab, Inc.'s stock price today?

  • The Gitlab, Inc. share price today is $40.70
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GTLB is experiencing slight selling pressure.

RYTM Stock Price Chart

What is Rhythm Pharmaceuticals, Inc.'s stock price today?

  • The Rhythm Pharmaceuticals, Inc. share price today is $104.77
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RYTM is experiencing slight buying pressure.

GTLB Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.63 Sell
Relative Strength Index (14 RSI): 45.23 Sell
Chaikin Money Flow: -462732 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

RYTM Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.1 Buy
Relative Strength Index (14 RSI): 51.18 Buy
Chaikin Money Flow: 492572 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

GTLB Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 39.42 Buy
20-day SMA: 41.17 Sell
50-day SMA: 44.62 Sell
200-day SMA: 46.35 Sell
8-day EMA: 39.9 Buy
20-day EMA: 41.26 Sell
50-day EMA: 43.54 Sell
200-day EMA: 47.22 Sell

RYTM Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 104 Buy
20-day SMA: 103.19 Buy
50-day SMA: 104.46 Buy
200-day SMA: 81.11 Buy
8-day EMA: 104.12 Buy
20-day EMA: 104.09 Buy
50-day EMA: 102.96 Buy
200-day EMA: 86.07 Buy

Gitlab, Inc. Earnings Growth & GTLB Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.08 per share, an increase next quarter of $0.00 per share, an increase this year of $0.50 per share, and an increase next year of $0.26 per share.

Rhythm Pharmaceuticals, Inc. Earnings Growth & RYTM Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.02 per share, and an increase next year of $0.56 per share.

Gitlab, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Rhythm Pharmaceuticals, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):